John Carpten, PhD

Dr. Carpten currently serves as Professor and Chair for the Department of Translational Genomics, and Director of the Institute for Translational Genomics, Keck School of Medicine, University of Southern California, Los Angeles, CA. He received his PhD in Molecular, Cellular and Developmental Biology from the Ohio State University. Prior to his current appointment at USC, he served as Professor and Deputy Director of Basic Sciences at the Translational Genomics Research Institute (TGen), Phoenix, AZ. Dr. Carpten’s expertise spans a very broad range of research disciplines including germline genetics, tumor profiling, cancer cell biology, functional genomics, and health disparities. The primary goal of Dr. Carpten’s research program is to discover molecular alterations in cancer and to translate these findings into new approaches for prevention, diagnosis and treatment. In support of this goal, his program is actively involved in the development and application of cutting-edge technologies and novel bioinformatics approaches for discovery research. Dr. Carpten has co-authored 190 publications in scientific journals that include Science, Nature, Nature  Genetics, Cancer Cell, Cancer Research, Molecular Cancer Therapeutics, and the New England Journal of Medicine. Dr. Carpten has an intense focus on understanding the role of biology in cancer health disparities. Through his leadership, the African American Hereditary Prostate Cancer Study (AAHPC) Network was conceived. This study has become a model for genetic studies in underrepresented populations and led to the first genome wide scan for prostate cancer susceptibility genes in African Americans. His work has impacted our understanding of a variety of cancer types that disproportionately affect racial and ethnic minorities including prostate cancer, breast cancer, colon cancer, brain cancer, multiple myeloma, and pediatric cancers. Dr. Carpten was names a Science Trailblazer by Spectrum Magazine in 2006, and was awarded the AACR and Susan G. Komen Distinguished Lectureship on the Science of Cancer Health Disparities in 2014, and the AACR Jane Cooke Wright Lectureship in 2018 for his untiring work in ensuring that all people are equally represented in science and innovative healthcare. In 2019, he served as Program Committee Chair for the AACR Annual Conference in Atlanta, GA, which included over 21,500 international participants. It is his hope that his efforts will lead to improvements in cancer management and outcomes for all patients.

BACK